CYP1B1 promotes PARPi-resistance via histone H1.4 interaction and increased chromatin accessibility in ovarian cancer
Drug Resistance Updates · 2024-11 · 77 · 101151
DOI: 10.1016/j.drup.2024.101151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2024-11. Verfasst von Yite Xue und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Zhejiang Key Laboratory of Precision …. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cytochrome P-450 CYP1B1, Drug Resistance, Neoplasm, Chromatin. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Technologies Research and Development Program, Key Research and Development Program of Zhejiang Province, Innovative Research Group Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Zhejiang Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospit…
- Department of Gynecology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, China; Zhejiang Provi…
Förderung
- Key Technologies Research and Development Program
- Key Research and Development Program of Zhejiang Province
- Innovative Research Group Project of the National Natural Science Foundation of China
Zitieren
APA
Xue, Y., Yin, T., Yuan, S., Wang, L., Lin, H., Jin, T., Xu, R., Gu, J., Shen, S., Chen, X., Chen, Z., Sima, N., Chen, L., Lu, W., Li, X., Cheng, X., & Wang, H. (2024). CYP1B1 promotes PARPi-resistance via histone H1.4 interaction and increased chromatin accessibility in ovarian cancer. Drug Resistance Updates, 77, 101151. https://doi.org/10.1016/j.drup.2024.101151
Vancouver
Xue Y, Yin T, Yuan S, Wang L, Lin H, Jin T, et al. CYP1B1 promotes PARPi-resistance via histone H1.4 interaction and increased chromatin accessibility in ovarian cancer. Drug Resistance Updates. 2024;77:101151. doi:10.1016/j.drup.2024.101151
BibTeX
@article{Xue2024,
author = {Xue, Yite and Yin, Taotao and Yuan, Shuo and Wang, Lingfang and Lin, Hui and Jin, Tianzhe and Xu, Ruiyi and Gu, Jiaxin and Shen, Shizhen and Chen, Xiaojing and Chen, Zhuoye and Sima, Ni and Chen, Lifeng and Lu, Weiguo and Li, Xiao and Cheng, Xiaodong and Wang, Hui},
title = {CYP1B1 promotes PARPi-resistance via histone H1.4 interaction and increased chromatin accessibility in ovarian cancer},
journal = {Drug Resistance Updates},
year = {2024},
volume = {77},
pages = {101151},
doi = {10.1016/j.drup.2024.101151}
}
EUVIMED